Recent scientific advances have both enlightened and complicated oncology clinical research. Key among them is the heterogeneity of tumors at the same primary site. The ensuing necessity for companion diagnostics to identify which patients will benefit from a targeted therapy and for rapid identification of molecules that can sidestep acquired resistance, plus progress in immunologic- and vaccine-based treatments, have increased the complexity of drug development.
At Worldwide Clinical Trials, our core oncology expertise means your trial starts from a favorable, advanced position. Our commitment to your study objectives and our ability to proactively identify and overcome operational challenges mitigate your risk.